RT Journal Article
SR Electronic
T1 Gastrointestinal symptoms as Covid-19 onset in hospitalized Italian patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.20.20064873
DO 10.1101/2020.04.20.20064873
A1 Buscarini, Elisabetta
A1 Manfredi, Guido
A1 Brambilla, Gianfranco
A1 Menozzi, Fernanda
A1 Londoni, Claudio
A1 Alicante, Saverio
A1 Iiritano, Elena
A1 Romeo, Samanta
A1 Pedaci, Marianna
A1 Benelli, Gianpaolo
A1 Canetta, Ciro
A1 Lapiana, Giuseppe
A1 Merli, Guido
A1 Scartabellati, Alessandro
A1 Viganò, Giovanni
A1 Sfogliarini, Roberto
A1 Melilli, Giovanni
A1 Assandri, Roberto
A1 Cazzato, Daniele
A1 Rossi, Davide Sebastiano
A1 Usai, Susanna
A1 Tramacere, Irene
A1 Pellegata, Germano
A1 Lauria, Giuseppe
YR 2020
UL http://medrxiv.org/content/early/2020/04/23/2020.04.20.20064873.abstract
AB Objective To assess the prevalence of gastrointestinal symptoms and their correlation with need of non-invasive ventilatory support, intensive care unit admission and death in hospitalized SARS-CoV-2 patients.Design Since February 21th 2020, all individuals referred to our emergency department for suspected SARS-CoV-2 underwent a standardized assessment of body temperature and pulse oximetry, hematological screening, chest X-ray and/or computed tomography (CT), and SARS-CoV-2 assay on nasopharyngeal swab. Medical history and GI symptoms including nausea, vomit, diarrhea, and abdominal pain were recorded. were recorded.Results GI symptoms were the main presentation in 42 (10.2%) of 411 patients, with a mean onset 4.9 +/-… days before admission. In 5 (1.2%) patients GI symptoms have not been associated with respiratory symptoms or fever. We found an inverse trend for ICU admission and death as compared with patients without GI symptoms.Conclusions GI symptoms can be an early and not negligible feature of Covid-19, and might be correlated with a more benign disease course.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialit is a prospective survey of COVID 19 patientsFunding Statementthe study has not been fundedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author.